NO20010355L - Nye peptider for anvendelse i immunterapi av autoimmune sykdommer - Google Patents

Nye peptider for anvendelse i immunterapi av autoimmune sykdommer

Info

Publication number
NO20010355L
NO20010355L NO20010355A NO20010355A NO20010355L NO 20010355 L NO20010355 L NO 20010355L NO 20010355 A NO20010355 A NO 20010355A NO 20010355 A NO20010355 A NO 20010355A NO 20010355 L NO20010355 L NO 20010355L
Authority
NO
Norway
Prior art keywords
immunotherapy
autoimmune diseases
new peptides
peptides
new
Prior art date
Application number
NO20010355A
Other languages
English (en)
Other versions
NO20010355D0 (no
Inventor
Gijsbertus Francisc Verheijden
Anna Maria Helena Boots
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20010355D0 publication Critical patent/NO20010355D0/no
Publication of NO20010355L publication Critical patent/NO20010355L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20010355A 1998-07-23 2001-01-22 Nye peptider for anvendelse i immunterapi av autoimmune sykdommer NO20010355L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98202470 1998-07-23
PCT/EP1999/005050 WO2000005254A2 (en) 1998-07-23 1999-07-16 Novel peptides for use in immunotherapy of autoimmune diseases

Publications (2)

Publication Number Publication Date
NO20010355D0 NO20010355D0 (no) 2001-01-22
NO20010355L true NO20010355L (no) 2001-03-20

Family

ID=8233961

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010355A NO20010355L (no) 1998-07-23 2001-01-22 Nye peptider for anvendelse i immunterapi av autoimmune sykdommer

Country Status (21)

Country Link
US (1) US6964766B1 (no)
EP (1) EP1100823A2 (no)
JP (1) JP2002521388A (no)
KR (1) KR20010071020A (no)
CN (1) CN1310724A (no)
AU (1) AU758310B2 (no)
BR (1) BR9912378A (no)
CA (1) CA2334947A1 (no)
CO (1) CO5090903A1 (no)
CZ (1) CZ2001286A3 (no)
HU (1) HUP0103384A3 (no)
ID (1) ID27998A (no)
IL (1) IL140825A0 (no)
NO (1) NO20010355L (no)
NZ (1) NZ509417A (no)
PE (1) PE20000931A1 (no)
PL (1) PL345958A1 (no)
RU (1) RU2233290C2 (no)
SK (1) SK1042001A3 (no)
TR (1) TR200100175T2 (no)
WO (1) WO2000005254A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
JP2006508014A (ja) 2001-07-24 2006-03-09 イエール・ユニバーシテイ キチナーゼおよびキチナーゼ様分子、ならびに炎症性疾患に関する方法、組成物およびキット
CN1169829C (zh) 2002-06-27 2004-10-06 北京大学人民医院 非t细胞结合肽及其用途
RU2374841C1 (ru) * 2008-04-22 2009-12-10 Государственное научное учреждение Всероссийский научно-исследовательский и технологический институт птицеводства Способ индукции иммунологической толерантности у птиц
RU2408603C1 (ru) * 2009-07-21 2011-01-10 Ибмед Холдингс Лимитед Олигопептид, обладающий активностью морфогенетического белка хрящевого происхождения (cdmp-1) по отношению к пролиферации хондроцитов
RU2667423C1 (ru) * 2017-06-28 2018-09-19 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ПраймБиоМед" Мышиная гибридома ykl-39, клон 1b2 g4 - продуцент моноклонального антитела, обладающего специфичностью к цитоплазматическому антигену ykl-39 человека

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9023116D0 (en) * 1990-10-24 1990-12-05 Fujisawa Pharmaceutical Co Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
DE4132005A1 (de) * 1991-09-26 1993-04-01 Merck Patent Gmbh Kombination enthaltend wachstumsfaktoren und polyelektrolyte
JPH07506810A (ja) * 1992-02-10 1995-07-27 デューク・ユニバーシティ 自己抗原である病原性のｔ細胞エピトープおよびｂ細胞エピトープに対する寛容性を誘導するための合成ペプチドの使用
AU4920093A (en) * 1992-09-14 1994-04-12 Brigham And Women's Hospital Reagents and methods for treating rheumatoid arthritis
IL115744A (en) 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
IL120561A0 (en) 1996-04-24 1997-07-13 Akzo Nobel Nv Peptides suitable for use in immunosuppressive therapy
EP0805206A3 (en) 1996-05-03 1999-09-15 Smithkline Beecham Corporation Human cartilage glycoprotein
AU6693996A (en) 1996-08-09 1998-03-06 Human Genome Sciences, Inc. Human chitinase alpha and chitinase alpha-2

Also Published As

Publication number Publication date
RU2001105086A (ru) 2004-01-20
BR9912378A (pt) 2001-04-17
RU2233290C2 (ru) 2004-07-27
CA2334947A1 (en) 2000-02-03
WO2000005254A3 (en) 2000-06-15
PL345958A1 (en) 2002-01-14
AU758310B2 (en) 2003-03-20
CO5090903A1 (es) 2001-10-30
NO20010355D0 (no) 2001-01-22
PE20000931A1 (es) 2000-09-16
JP2002521388A (ja) 2002-07-16
WO2000005254A2 (en) 2000-02-03
IL140825A0 (en) 2002-02-10
US6964766B1 (en) 2005-11-15
NZ509417A (en) 2003-03-28
CZ2001286A3 (en) 2001-08-15
HUP0103384A3 (en) 2004-06-28
CN1310724A (zh) 2001-08-29
EP1100823A2 (en) 2001-05-23
HUP0103384A2 (hu) 2001-12-28
AU5411299A (en) 2000-02-14
SK1042001A3 (en) 2001-09-11
TR200100175T2 (tr) 2001-09-21
KR20010071020A (ko) 2001-07-28
ID27998A (id) 2001-05-03

Similar Documents

Publication Publication Date Title
NO995134L (no) Forbedrede fremgangsmåter for fremstilling av aktivert protein C
FI962619L (fi) Autoantigeenistä johdettuja uusia peptidejä autoimmuunitautien immunoterapiassa käyttöä varten
EP0853483A4 (en) NEW PEPTIDES
DE60028358D1 (de) Hmg1 antagonisten zur behandlung von entzündungen
ID19305A (id) Formulasi peptida berair
FI965225L (fi) Uusia peptidejä
NO984835L (no) Autoantigen og proteiner strukturelt relatert til dette for anvendelse i immunoterapi av autoimmune sykdommer
NO20006113D0 (no) Anvendelse av cyklosporiner i behandlingen av inflammatoriske autoimmune sykdommer
NO985680D0 (no) Peptidderivater
NO984937D0 (no) Nye peptider egnet for anvendelse i antigenspesifikk immunundertrukkende behandling
DK0770132T3 (da) Nye streptograminer
NO983849D0 (no) Peptidderivater
NO20010355D0 (no) Nye peptider for anvendelse i immunterapi av autoimmune sykdommer
PL332282A1 (en) Application of proteins as factors against autoimmunological diseases
IL154357A0 (en) Stress proteins and peptides and methods of use thereof
EP1012262A4 (en) Human frezzled-like protein
NO20024458D0 (no) Anvendelse av MIA i immunoterapi
NO20000961D0 (no) Nye vevs-spesifikke calpainer, samt fremgangsmåte for fremstilling og anvendelse derav
DE69735872D1 (de) Menschliches adhäsionsmolekül occludin
IL148572A0 (en) Self-cleaving rna sequences and their use for the control of protein synthesis
NO20006091D0 (no) Humant protein C-polypeptid
FI950211A7 (fi) Huokosia muodostavia peptidejä Geolycosa riograndesta
SE9602287D0 (sv) Novel protein and methods for its use
ID30211A (id) Protein baru dan penggunaannya
SI0928197T1 (en) Use of proteins as agents against autoimmune diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application